
OncoTherapy Science, Inc.
4564 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 川崎市川崎区東田町1番地2
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
OncoTherapy Science, Inc. (OTS) is a Japanese biotechnology company focused on the discovery and development of molecular-targeted anti-cancer therapies. OTS has identified numerous cancer-specific genes that are critical for creating innovative treatments. The company conducts extensive medicinal research to understand the subcellular localization, functionality, and immunogenicity of these genes. In addition to drug development, OTS offers comprehensive analysis services utilizing advanced next-generation sequencing technology to assess TCR repertoires from blood and tissue samples. Committed to high efficacy and minimized adverse effects, OTS collaborates with renowned genomics expert Professor Yusuke Nakamura to advance its mission in the battle against cancer.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for OncoTherapy Science, Inc..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-26 03:49 |
Regulatory News Service
臨時報告書
|
Japanese | 21.9 KB | |
2025-06-24 09:11 |
Regulatory News Service
内部統制報告書-第24期(2024/04/01-2025/03/31)
|
Japanese | 22.8 KB | |
2025-06-24 09:10 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
2025-06-24 09:09 |
Annual Report
有価証券報告書-第24期(2024/04/01-2025/03/31)
|
Japanese | 976.0 KB | |
2025-04-10 08:33 |
Prospectus
有価証券届出書(組込方式)
|
Japanese | 404.8 KB | |
2025-02-18 01:06 |
Regulatory News Service
臨時報告書
|
Japanese | 21.4 KB | |
2024-11-11 01:25 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
2024-11-11 01:23 |
Interim Report
半期報告書-第24期(2024/04/01-2025/03/31)
|
Japanese | 272.5 KB | |
2024-06-28 08:58 |
Regulatory News Service
臨時報告書
|
Japanese | 22.8 KB | |
2024-06-25 09:30 |
Regulatory News Service
内部統制報告書-第23期(2023/04/01-2024/03/31)
|
Japanese | 22.9 KB | |
2024-06-25 09:29 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
2024-06-25 09:26 |
Annual Report
有価証券報告書-第23期(2023/04/01-2024/03/31)
|
Japanese | 1007.8 KB | |
2024-04-05 08:07 |
Prospectus
有価証券届出書(組込方式)
|
Japanese | 368.3 KB | |
2024-02-16 08:53 |
Regulatory News Service
臨時報告書
|
Japanese | 22.1 KB | |
2024-02-13 01:17 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB |
Automate Your Workflow. Get a real-time feed of all OncoTherapy Science, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for OncoTherapy Science, Inc. via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |